Sales of shingles vaccine boost profits at GSK

Sales of shingles vaccine boost profits at GSK

Source: 
Yahoo/Reuters
snippet: 

Sales of shingles vaccines boosted GlaxoSmithKline Plc's profits in the final quarter of 2018, allaying investor concerns about Britain's biggest drugmaker's prospects beyond its blockbuster Advair asthma drug.